NCT03411850View on ClinicalTrials.gov

Sjogrens Syndrome Measured by Ultrasound

PHASE2UnknownINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

May 31, 2021

Study Completion Date

December 31, 2021

Conditions

Sjogren's Syndrome

Interventions

BIOLOGICAL

Orencia

FDA approved biologic

OTHER

Placebo

Trial Locations (1)

20902

The Center for Rheumatology and Bone Research a division of Arthritis and Rheumatism Associates, P.C., Wheaton

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Arthritis & Rheumatism Associates, P.C.

OTHER

NCT03411850 - Sjogrens Syndrome Measured by Ultrasound | Biotech Hunter | Biotech Hunter